Newark, New Castle, USA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Leadless Cardiac Pacemaker Market by Type (Micra Transcatheter Pacing System, Wireless Cardiac Simulation System, Nanostim Leadless Cardiac Pacemaker), by Condition (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block) – Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the Leadless Cardiac Pacemaker market is expected to grow at a CAGR of 17.9% from 2021 to reach US$ 466.5 million by 2030. Owing to a rise in the prevalence of cardiovascular diseases and growing demand for minimally invasive procedures.
Download PDF Brochure on Leadless Cardiac Pacemaker Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.growthplusreports.com/inquiry/request-sample/leadless-cardiac-pacemaker-market/8048
Market Drivers
The leading drivers of the global leadless cardiac pacemakers market are the increasing prevalence of cardiovascular disorders and the growing elderly population. In addition, complications such as pocket infections, hematomas, lead dislodgment, and lead fracture are less common with leadless pacemakers than with conventional ones. The demand for minimally invasive cardiac operations over open surgeries is growing because of shorter hospital stays, a decreased risk of infection and bleeding, and a quicker recovery. Additionally, the increased R&D for leadless pacemakers and the integration of cutting-edge technologies like AI with pacemakers are accelerating the growth of the global market. Furthermore, because there is no chest incision and visible pacemaker pocket, and the size of the leadless pacemaker is smaller than the size of the transvenous pacemaker, there is a consistently high demand for leadless pacemakers.
The global leadless cardiac pacemaker market has been analyzed from three perspectives – type, Condition, and region.
Excerpts from ‘By Type Segmentation’
Based on types, the global leadless cardiac pacemaker market is divided into:
- Micra Transcatheter Pacing Systems
- Wireless Cardiac Simulation Systems
- Nanostim Leadless Cardiac Pacemakers
The Micra transcatheter pacing system dominates the global leadless cardiac pacemaker market with the largest market share in 2021. A less invasive process is used to install the Micra transcatheter pacing device in the chest, leaving no visible scars and shortening hospital stays, contributing to the segment growth. The Micra transcatheter pacing system is self-contained and 90% smaller than a typical pacemaker, which also plays a vital role in segment growth. Furthermore, patients with the Micra transcatheter pacing device can have MRI scans, allowing a constant demand. Additionally, the system adjusts the heart rate automatically based on changes in the body, such as physical activity. The battery of the devices is expected to last between 10 and 12 years, driving the segment's expansion.
Excerpts from ‘By Condition Segmentation’
Based on Condition, the global leadless cardiac pacemaker market is categorized into:
- Atrial fibrillation
- Sinus Node Dysfunction
- Atrioventricular Block
The atrial fibrillation segment will hold the largest market share of the global leadless cardiac pacemaker market in 2021. The increased prevalence of atrial fibrillation can be attributable to its leading share. Globally, atrial fibrillation is the most prevalent kind of arrhythmia. Additionally, the growing elderly population, which is more susceptible to atrial fibrillation, is crucial to the segment's expansion. Furthermore, the segment is growing as a result of an increase in the consumption of alcohol and tobacco combined with a decline in physical activity.
Excerpts from ‘By Region Segmentation’
Based on region, the global leadless cardiac pacemaker market has been segmented into:
- North America
- Europe
- Asia Pacific
- Rest of the World
North America dominated the global leadless cardiac pacemaker market in 2021. A significant aspect driving regional growth is the increased incidence of atrial fibrillation in the area. According to the Centers for Disease Control and Prevention (CDC), in the U.S. approximately 454,000 hospitalizations take place due to atrial fibrillation, which causes around 158,000 deaths each year. Additionally, the region's expansion is aided by the availability of well-developed healthcare infrastructure and favorable reimbursement policies. The presence of prominent market players in the area is also projected to fuel regional growth.
Browse the full report with detailed TOC at: https://www.growthplusreports.com/report/leadless-cardiac-pacemaker-market/8048
Excerpts from ‘Competitive Landscape’
The prominent global leadless cardiac pacemaker market is:
- Medtronic Plc
- Abbott Laboratories Inc.
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- SORIN S.p.A
- Edward Lifesciences Corporation
- Vitatron
- Lepu Medical Technology
- Terumo Corporation
- MEDICO S.p.A.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy now complete report here: https://www.growthplusreports.com/checkout-8048
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
